Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marios K Georgakis

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
International Journal of Epidemiology|May 13, 2020
Genetic instrument selection for Mendelian randomization explorations of drug target effectsMarios K Georgakis
JACC. Basic to Translational Science|October 29, 2025
Data-Driven Discovery of Novel Biology: From Genetics and Omics to Therapeutic Targets for Vascular DiseaseMarios K Georgakis
Stroke|August 17, 2021
Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic DataMarios K Georgakis, Dipender Gill
Neurology|March 4, 2020
Author response: WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysisMarios K Georgakis, Martin Dichgans
JAMA Cardiology|March 3, 2021
Serum Monocyte-Chemoattractant Protein-1 Could Be an Indicator of Coronary Artery Calcium Score-ReplyMarios K Georgakis, Martin Dichgans
Cells|August 9, 2024
Translating Anti-Inflammatory Strategies for Atherosclerosis: Deep Phenotyping, Next-Generation Drug Targets, and Precision MedicineYaw Asare, Marios K Georgakis
Stroke|November 2, 2022
International Section for Early Career and TrainingMarios K Georgakis, Rainer Malik
Neurology|May 31, 2019
Remote ischemic preconditioning effects on brain vasculaturePaul Nyquist, Marios K Georgakis
Current Atherosclerosis Reports|March 13, 2026
Genetic Variation in the Chemokine Network and Atherosclerosis RiskPanagiotis Zangas, Marios K Georgakis
JAMA Network Open|November 11, 2021
Long-term Risk of Cognitive Impairment and Dementia Following Bilateral Oophorectomy in Premenopausal Women-Time to Rethink Policies?Marios K Georgakis, Eleni T Petridou
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
International Journal of Epidemiology|May 13, 2020
Genetic instrument selection for Mendelian randomization explorations of drug target effectsMarios K Georgakis
JACC. Basic to Translational Science|October 29, 2025
Data-Driven Discovery of Novel Biology: From Genetics and Omics to Therapeutic Targets for Vascular DiseaseMarios K Georgakis
Stroke|August 17, 2021
Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic DataMarios K Georgakis, Dipender Gill
Neurology|March 4, 2020
Author response: WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysisMarios K Georgakis, Martin Dichgans
JAMA Cardiology|March 3, 2021
Serum Monocyte-Chemoattractant Protein-1 Could Be an Indicator of Coronary Artery Calcium Score-ReplyMarios K Georgakis, Martin Dichgans
Cells|August 9, 2024
Translating Anti-Inflammatory Strategies for Atherosclerosis: Deep Phenotyping, Next-Generation Drug Targets, and Precision MedicineYaw Asare, Marios K Georgakis
Stroke|November 2, 2022
International Section for Early Career and TrainingMarios K Georgakis, Rainer Malik
Neurology|May 31, 2019
Remote ischemic preconditioning effects on brain vasculaturePaul Nyquist, Marios K Georgakis
Current Atherosclerosis Reports|March 13, 2026
Genetic Variation in the Chemokine Network and Atherosclerosis RiskPanagiotis Zangas, Marios K Georgakis
JAMA Network Open|November 11, 2021
Long-term Risk of Cognitive Impairment and Dementia Following Bilateral Oophorectomy in Premenopausal Women-Time to Rethink Policies?Marios K Georgakis, Eleni T Petridou
Pageof 17